Literature DB >> 14740109

[Paraganglioma in the area of the head and neck. A review of molecular genetic research].

S Braun1, K Riemann, C M Pusch, K Sotlar, M Pfister, S Kupka.   

Abstract

Paragangliomas of the head and neck region are usually benign tumors that develop from chemoreceptors of paraganglionic origin in the majority of patients. These receptors play an important role in sensing and regulation of the blood CO(2) level. Genetic alterations in the mitochondrial enzyme complex II (SDH), which is involved in respiratory chain and citric acid cycle reactions, have been shown to lead to sporadic as well as familial cases of these tumors. The gene encoding the subunit SDHD shows mutations in up to 50% of these cases. In addition, loss of heterozygosity (LOH) was demonstrated in these tumor samples and has been shown to be connected with oncogenesis of paragangliomas. Thus, SDHD is the first known tumor suppressor gene encoding a mitochondrial protein. In this article we summarize the current state of knowledge concerning the development of paragangliomas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14740109     DOI: 10.1007/s00106-003-0959-y

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  35 in total

Review 1.  Mitochondria and apoptosis.

Authors:  D R Green; J C Reed
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

Review 2.  [Clinical significance of tumor suppressor gene p53 in head and neck tumors].

Authors:  V Preisler; S Kirchner; R Hagen
Journal:  HNO       Date:  1997-09       Impact factor: 1.284

3.  Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

Authors:  J Yang; X Liu; K Bhalla; C N Kim; A M Ibrado; J Cai; T I Peng; D P Jones; X Wang
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

4.  Novel mutations in the SDHD gene in pedigrees with familial carotid body paraganglioma and sensorineural hearing loss.

Authors:  R F Badenhop; S Cherian; R S Lord; B E Baysal; P E Taschner; P R Schofield
Journal:  Genes Chromosomes Cancer       Date:  2001-07       Impact factor: 5.006

5.  [Polytopic manifestations of paragangliomas. Diagnosis, differential diagnosis and indications for therapy].

Authors:  J Hoffmann; S M Kröber; U Hahn; U Ernemann; S Reinert
Journal:  Mund Kiefer Gesichtschir       Date:  2000-01

6.  Characterization of the human SDHD gene encoding the small subunit of cytochrome b (cybS) in mitochondrial succinate-ubiquinone oxidoreductase.

Authors:  H Hirawake; M Taniwaki; A Tamura; H Amino; E Tomitsuka; K Kita
Journal:  Biochim Biophys Acta       Date:  1999-08-04

7.  Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.

Authors:  B E Baysal; J E Willett-Brozick; E C Lawrence; C M Drovdlic; S A Savul; D R McLeod; H A Yee; D E Brackmann; W H Slattery; E N Myers; R E Ferrell; W S Rubinstein
Journal:  J Med Genet       Date:  2002-03       Impact factor: 6.318

8.  The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway.

Authors:  A P Gimenez-Roqueplo; J Favier; P Rustin; J J Mourad; P F Plouin; P Corvol; A Rötig; X Jeunemaitre
Journal:  Am J Hum Genet       Date:  2001-10-16       Impact factor: 11.025

9.  Jugular body tumors: hyperplasias or true neoplasms? Light and electron microscopical investigations.

Authors:  D Stiller; D Katenkamp; K Küttner
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975

10.  Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region.

Authors:  D L Van Dyke; M J Worsham; M S Benninger; C J Krause; S R Baker; G T Wolf; T Drumheller; B C Tilley; T E Carey
Journal:  Genes Chromosomes Cancer       Date:  1994-03       Impact factor: 5.006

View more
  1 in total

1.  Paragangliomas and paraganglioma syndromes.

Authors:  Carsten Christof Boedeker
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-04-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.